Skip to Main Content

INFORMATION FOR

Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy

Conditions

Diseases of the Nervous System | Mental Health & Behavioral Research

What is the purpose of this trial?

WHAT IS THE HEP3 STUDY?

The HEP3 Study is a research project to better understand what happens over time in people with focal seizures that don’t respond to current treatment.

What do I need to do if I join the study?

  1. Keep track of your seizures and medications using the Seer App seizure or paper diary
  2. Answer questions about your medical history and your seizures
  3. Visit the study team up to 3 times up to a period of two years for health exams and blood tests.
  4. Complete surveys about your quality of life, mood, mental functioning, general health, and healthcare visits or tests.
  5. Participants receive compensation for each study visit.

WHO CAN PARTICIPATE?

If you answer yes to the two questions below, you may be eligible to participate!

  1. Have you been recently diagnosed with idiopathic generalized epilepsy, and have 1 (absence, myoclonus, or generalized tonic clonic convulsion) seizure in the 6 months prior to treatment?
  2. Have you instituted AED treatment (for seizures no more than 12 months ago?

Contact the Yale HEP Team

  • Trial with
    NYU Grossman School of Medicine
  • Start Date
    12/11/2020
  • End Date
    12/31/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/15/2022
  • Study HIC
    #2000027419